717 related articles for article (PubMed ID: 30138730)
1. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
2. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
[TBL] [Abstract][Full Text] [Related]
4. Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery.
Hwang JY; Aum DJ; Chicoine MR; Dacey RG; Osbun JW; Rich KM; Zipfel GJ; Klatt-Cromwell CN; McJunkin JL; Pipkorn P; Schneider JS; Silverstein JM; Kim AH
Pituitary; 2020 Aug; 23(4):389-399. PubMed ID: 32388803
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
Shao S; Li X
J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
[TBL] [Abstract][Full Text] [Related]
6. Is Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing Hormone Associated with a Poor Prognosis?
Diri H; Ozaslan E; Kurtsoy A; Tucer B; Simsek Y; Ozturk F; Durak AC; Erten S; Bayram F
Turk Neurosurg; 2017; 27(1):8-13. PubMed ID: 27593756
[TBL] [Abstract][Full Text] [Related]
7. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
9. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.
Lee JYK; Cho SS; Zeh R; Pierce JT; Martinez-Lage M; Adappa ND; Palmer JN; Newman JG; Learned KO; White C; Kharlip J; Snyder P; Low PS; Singhal S; Grady MS
J Neurosurg; 2018 Aug; 129(2):390-403. PubMed ID: 28841122
[TBL] [Abstract][Full Text] [Related]
11. Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence.
Kirkman MA; Jaunmuktane Z; Brandner S; Khan AA; Powell M; Baldeweg SE
World Neurosurg; 2014 Dec; 82(6):1224-31. PubMed ID: 24657816
[TBL] [Abstract][Full Text] [Related]
12. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
13. Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.
Caretto A; Lanzi R; Piani C; Molgora M; Mortini P; Losa M
Pituitary; 2017 Oct; 20(5):553-560. PubMed ID: 28676954
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.
Langlois F; Lim DST; Varlamov E; Yedinak CG; Cetas JS; McCartney S; Dogan A; Fleseriu M
Endocrine; 2017 Dec; 58(3):528-534. PubMed ID: 29043561
[TBL] [Abstract][Full Text] [Related]
16. Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone.
Sen O; Ertorer ME; Aydin MV; Erdogan B; Altinors N; Zorludemir S; Guvener N
J Clin Neurosci; 2005 Apr; 12(3):318-20. PubMed ID: 15851094
[TBL] [Abstract][Full Text] [Related]
17. Changes in hormone production of a recurrent silent corticotroph adenoma of the pituitary: a histologic, immunohistochemical, ultrastructural, and tissue culture study.
Felix I; Asa SL; Kovacs K; Horvath E
Hum Pathol; 1991 Jul; 22(7):719-21. PubMed ID: 1649119
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA.
Øystese KA; Casar-Borota O; Normann KR; Zucknick M; Berg JP; Bollerslev J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3581-3590. PubMed ID: 28911153
[TBL] [Abstract][Full Text] [Related]
19. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
[TBL] [Abstract][Full Text] [Related]
20. A silent follicle-stimulating hormone-producing pituitary adenoma in a teenage male.
Tamiya H; Fukuhara N; Yoshida N; Suzuki H; Takeshita A; Inoshita N; Nishioka H; Takeuchi Y; Sano T; Yamada S
Endocr Pathol; 2011 Dec; 22(4):212-7. PubMed ID: 21853289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
